Abstract:Epilepsy Currents, Ahead of Print. Conserved Patterns Across Ion Channels Correlate With Variant Pathogenicity and Clinical Phenotypes Brünger T, Pérez-Palma E, Montanucci L, Nothnagel M, Møller RS, Schorge S, Zuberi S, Symonds J, Lemke JR, Brunklaus A, Traynelis SF, May P, Lal D. Brain. 2022:awac305. doi:10.1093/brain/awac305. Epub ahead of print. PMID: 36036558.Clinically identified genetic variants in ion channels can be benign or cause disease by increasing or decreasing the protein function. Consequently, therapeutic decision-making is challenging without molecular testing of each variant. Our biophysical knowledge of ion channel structures and function is just emerging, and it is currently not well understood which amino acid residues cause disease when mutated. We sought to systematically identify biological properties associated with variant pathogenicity across all major voltage and ligand-gated ion channel families. We collected and curated 3,049 pathogenic variants from hundreds of neurodevelopmental and other disorders and 12,546 population variants for 30 ion channel or channel subunits for which a high-quality protein structure was available. Using a wide range of bioinformatics approaches, we computed 163 structural features and tested them for pathogenic variant enrichment. We developed a novel 3D spatial distance scoring approach that enables comparisons of pathogenic and population variant distribution across protein structures. We discovered and independently replicated that several pore residue properties and proximity to the pore axis were most significantly enriched for pathogenic variants compared to population variants. Using our 3D scoring approach, we showed that the strongest pathogenic variant enrichment was observed for pore-lining residues and alpha-helix residues within 5 Å distance from the pore axis center and not involved in gating. Within the subset of residues located at the pore, the hydrophobicity of the pore was the feature most strongly associated with variant pathogenicity. We also found an association between the identified properties and both clinical phenotypes and functional in vitro assays for voltage-gated sodium channels (SCN1A, SCN2A, SCN8A) and N-methyl-D-aspartate (NMDA) receptor (GRIN1, GRIN2A, GRIN2B) encoding genes. In an independent expert-curated dataset of 1,422 neurodevelopmental disorder pathogenic patient variants and 679 electrophysiological experiments, we show that pore axis distance is associated with seizure age of onset and cognitive performance as well as differential gain vs. loss-of-channel function. In summary, we identified biological properties associated with ion-channel malfunction and show that these are correlated with in vitro functional read-outs and clinical phenotypes in patients with neurodevelopmental disorders. Our results suggest that clinical decision support algorithms that predict variant pathogenicity and function are feasible in the future.

Channeling the Future of Pathogenicity Prediction for Genetic Variants in Epilepsy

No Pain, No Gain of Function: Epilepsy-Associated Variants in SCN2A Defy Classification

Optimizing clinical interpretability of functional evidence in epilepsy-related ion channel variants

Pathogenicity of de novo CACNA1D Ca 2+ channel variants predicted from sequence co-variation

Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties

Biological concepts in human sodium channel epilepsies and their relevance in clinical practice

Distances from ligands as main predictive features for pathogenicity and functional effect of variants in NMDA receptors

Hyperexcitability and Pharmacological Responsiveness of Cortical Neurons Derived from Human Ipscs Carrying Epilepsy-Associated Sodium Channel Nav1.2-L1342P Genetic Variant.

Novel HCN1 Mutations Associated With Epilepsy and Impacts on Neuronal Excitability

Novel Mutations and Phenotypes of Epilepsy-Associated Genes in Epileptic Encephalopathies.

Improved classification and pathogenicity assessment by comprehensive functional studies in a large data set of KCNQ2 variants

Mapping structural distribution and gating-property impacts of disease-associated mutations in voltage-gated sodium channels

Variant‐specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy

Preface: Special issue: "Ion channels and genetic epilepsy"

Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability

High-throughput Evaluation of Epilepsy-associated KCNQ2 Variants Reveals Functional and Pharmacological Heterogeneity

Expanded clinical phenotype spectrum correlates with variant function in SCN2A-related disorders

Molecular and cellular context influences SCN8A variant function

Two epilepsy-associated variants in KCNA2 (KV 1.2) at position H310 oppositely affect channel functional expression

Analysis of epilepsy-associated variants in HCN3 - Functional implications and clinical observations

Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy